Antipsychotic dose reduction compared to dose continuation for people with schizophrenia

Irene Bighelli; Myrto T. Samara; Alessandro Rodolico; Wulf Peter Hansen; Stefan Leucht

doi:10.1002/14651858.CD014384

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia

Irene Bighelli, Myrto T. Samara, Alessandro Rodolico, Wulf Peter Hansen, Stefan Leucht

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects and safety of reducing antipsychotic dose compared to continuing the dose for people with schizophrenia. To examine factors of dose reduction such as its degree and rapidity.

Original language	English
Article number	CD014384
Journal	Cochrane Database of Systematic Reviews
Volume	2021
Issue number	4
DOIs	https://doi.org/10.1002/14651858.CD014384
State	Published - 21 Apr 2021
Externally published	Yes

Access to Document

10.1002/14651858.CD014384

Cite this

@article{46bc10bb14b144c4b6e8e6201785f3ae,

title = "Antipsychotic dose reduction compared to dose continuation for people with schizophrenia",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects and safety of reducing antipsychotic dose compared to continuing the dose for people with schizophrenia. To examine factors of dose reduction such as its degree and rapidity.",

author = "Irene Bighelli and Samara, {Myrto T.} and Alessandro Rodolico and Hansen, {Wulf Peter} and Stefan Leucht",

note = "Publisher Copyright: Copyright {\textcopyright} 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2021",

month = apr,

day = "21",

doi = "10.1002/14651858.CD014384",

language = "English",

volume = "2021",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Antipsychotic dose reduction compared to dose continuation for people with schizophrenia

AU - Bighelli, Irene

AU - Samara, Myrto T.

AU - Rodolico, Alessandro

AU - Hansen, Wulf Peter

AU - Leucht, Stefan

PY - 2021/4/21

Y1 - 2021/4/21

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects and safety of reducing antipsychotic dose compared to continuing the dose for people with schizophrenia. To examine factors of dose reduction such as its degree and rapidity.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects and safety of reducing antipsychotic dose compared to continuing the dose for people with schizophrenia. To examine factors of dose reduction such as its degree and rapidity.

UR - http://www.scopus.com/inward/record.url?scp=85104680121&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD014384

DO - 10.1002/14651858.CD014384

M3 - Article

AN - SCOPUS:85104680121

SN - 1465-1858

VL - 2021

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 4

M1 - CD014384

ER -

Antipsychotic dose reduction compared to dose continuation for people with schizophrenia

Abstract

Access to Document

Other files and links

Fingerprint

Cite this